Skip to Content

93 7244 (Clarithromycin Extended Release 500 mg)

Pill with imprint 93 7244 is Yellow, Elliptical / Oval and has been identified as Clarithromycin Extended Release 500 mg. It is supplied by Teva Pharmaceuticals USA.

Clarithromycin is used in the treatment of dental abscess; bronchitis; bacterial endocarditis prevention; helicobacter pylori infection; pneumonia and belongs to the drug class macrolides. Risk cannot be ruled out during pregnancy. Clarithromycin 500 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 93 7244

Clarithromycin extended release 500 mg 93 7244 Front
Clarithromycin extended release 500 mg 93 7244 Back
Clarithromycin extended release 500 mg 93 7244
Clarithromycin extended release 500 mg 93 7244

Clarithromycin Extended Release

Imprint
93 7244
Strength
500 mg
Color
Yellow
Size
21.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Macrolides
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA
Inactive Ingredients
citric acid anhydrous, ethylcellulose (7 mPa.s), hypromellose 2910 (15 mPa.s), ferrosoferric oxide, ferric oxide red, ferric oxide yellow, lactose monohydrate, microcrystalline cellulose, polyethylene glycol 4000, corn starch, silicon dioxide, sodium starch glycolate type A potato, sodium stearyl fumarate, titanium dioxide, vanillin

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00093-7244 Teva Pharmaceuticals USA, Inc.
51862-0194 Libertas Pharma

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.